Veterinary Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Companion Animals, Production Animals); By Product Type; By Application; By Disease Type; By Region, And Segment Forecasts, 2023 - 2032

Veterinary Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Companion Animals, Production Animals); By Product Type; By Application; By Disease Type; By Region, And Segment Forecasts, 2023 - 2032

The global veterinary biomarkers market size is expected to reach USD 2,554.79 million by 2032, according to a new study by Polaris Market Research. The report “Veterinary Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Companion Animals, Production Animals), By Product Type, By Application, By Disease Type, By Region, And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Market growth is primarily driven by the rising incidence of acute and chronic diseases in animals, alongside the growing demand for advanced diagnostic and monitoring technologies with improved accuracy. The American Veterinary Medical Association reports that nearly half of the dog population is experiencing cancer at a similar rate to humans. This highlights the need for specialized diagnostic kits based on biomarkers, enabling timely disease prediction and effective treatments.

Growing expenditure on animal care in both developing and developed economies presents a substantial opportunity for market expansion. In the United States, pet owners have been increasingly investing in the wellness and healthcare products for their pets, as indicated by data from the American Kennel Club (AKC). The American Pet Products Association also reported that the sales in the overall pet industry surpassed USD 140 million by the end of 2022. Moreover, there has been significant research and development activity in the veterinary field, particularly in areas such as biomarkers, over the past decade. These factors are anticipated to drive the growth of the market, providing favorable conditions for its advancement.

Animal health industry faced significant barriers and challenges during the COVID-19 pandemic, including disruptions in marketing and sales activities, reduced veterinary clinic visits, cancellations of routine pet check-ups, and a decrease in diagnostic tests conducted in veterinary hospitals. However, governments & veterinary organizations in different countries implemented strategies & safety measures to resume the veterinary practices &relevant research activities amidst the pandemic. To mitigate the impact of lockdowns, telemedicine services were widely adopted in veterinary clinics and hospitals, allowing remote consultations and diagnoses. Additionally, pet owners were provided with digital training to use specific diagnostic kits, enabling them to participate in the diagnostic process remotely.

Veterinary Biomarkers Market Report Highlights

Companion animal segment held the largest share, primarily high adoption rate of cats & dogs in developed nations

Biomarker & kits segment dominated the market, due to the advancements in genomic technologies to find specific biomarkers

Disease diagnostics segment garnered the largest share, owing to launch of innovative biomarker-based test kits

North America led the market, with awareness among consumers and high adoption rate of pets

The global key market players include Merck, Zoetis, ACUVET BIOTECH, IDEXX Laboratories, Virbac, and Life Diagnostics.

Polaris Market Research has segmented the veterinary biomarkers market report based on animal type, product type, application, disease type, and region:

Veterinary Biomarkers, Animal Type Outlook (Revenue - USD Million, 2023 - 2032)

Companion Animals

Dogs

Cats

Others

Production Animals

Cows

Pigs

Others

Veterinary Biomarkers, Product Type Outlook (Revenue - USD Million, 2023 - 2032)

Biomarkers, Kits & Reagents

Biomarker Readers

Veterinary Biomarkers, Application Outlook (Revenue - USD Million, 2023 - 2032)

Disease Diagnostics

Preclinical Research

Others

Veterinary Biomarkers, Disease Type Outlook (Revenue - USD Million, 2023 - 2032)

Inflammatory & Infectious Diseases

Cardiovascular Diseases

Skeletal Muscle Diseases

Tumor

Others

Veterinary Biomarkers, Regional Outlook (Revenue - USD Million, 2023 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa